CARNEGIE CAPITAL ASSET MANAGEMENT, LLC – CRISPR Therapeutics AG Transaction History
CARNEGIE CAPITAL ASSET MANAGEMENT, LLC portfolio value:
$3.81M
portfolio value
CARNEGIE CAPITAL ASSET MANAGEMENT, LLC quarter portfolio value change:
+7.54%
quarter
CRISPR Therapeutics AG 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -33.01% | -28.77K shares | -1.48M | $65.35 | 58.38K |
| Q2 2022 | share | Increase | +1.15% | 989 shares | -112K | $60.77 | 87.15K |
| Q1 2022 | share | Decrease | -27.20% | -32.18K shares | -3.56M | $62.77 | 86.16K |
| Q4 2021 | share | Decrease | -0.48% | -575 shares | -4.34M | $78.85 | 118.35K |
| Q3 2021 | share | Increase | +1.50% | 1.75K shares | -5.65M | $111.93 | 118.92K |
| Q2 2021 | share | Increase | +7.02% | 7.69K shares | 5.62M | $161.89 | 117.17K |
| Q1 2021 | share | Increase | +16.23% | 15.28K shares | -1.08M | $121.85 | 109.48K |
| Q4 2020 | share | Increase | +5.52% | 4.92K shares | 6.95M | $153.11 | 94.19K |
| Q3 2020 | share | Decrease | -2.68% | -2.45K shares | 725K | $83.64 | 89.26K |
| Q2 2020 | share | Increase | +38.42% | 25.46K shares | 3.93M | $73.49 | 91.72K |
| Q1 2020 | share | Increase | +76.18% | 28.65K shares | 519K | $42.41 | 66.26K |
| Q4 2019 | share | Increase | +49.42% | 12.44K shares | 1.25M | $60.91 | 37.61K |
| Q3 2019 | share | Increase | +11.37% | 2.57K shares | -32K | $40.99 | 25.17K |
| Q2 2019 | share | Increase | 0.00% | 22.6K shares | 1.06M | $47.1 | 22.6K |